Press releases Archives - Page 7 of 13

Press releases

Feb

2025

Elisabeth Parker appointed as Business development expert in Hamlet BioPharma and joins the team on March 3rd

Hamlet Biopharma

Hamlet BioPharma has appointed Elisabeth Parker, PhD to strengthen the business development expertise in the company. Dr. Parker has 25 years’ experi...

Feb

2025

Catharina Svanborg appointed as CEO and assumes the position immediately, board member Magnus Nylén acting Chairman

Hamlet Biopharma

Press releases

The Board of Hamlet BioPharma has today decided to appoint Catharina Svanborg as CEO. Catharina immediately assumes the CEO role and continues as a B...

Feb

2025

Q2 Interim Report October 2024 – December 2024

Hamlet Biopharma

Financial, Press releases

...

Feb

2025

Hamlet BioPharma bjuder in till pressträff den 13 februari med anledning av Q2 rapport

Hamlet Biopharma

Press releases

Med anledning av bolagets kvartalsrapport 2 för 2024/2025, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdagen den 13 februari, 2...

Feb

2025

Presentation den 6.2.25 på Vetenskapsrådets konferens kring Antibiotikaresistens

Hamlet Biopharma

Press releases

Hamlet BioPharma AB, det innovativa läkemedelsbolaget, som utvecklar nya terapier mot cancer och infektioner, meddelar två viktiga händelser. Den 6 f...

Jan

2025

Invitation to monthly digital events and presentations of quarterly reports

Hamlet Biopharma

Press releases

Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuab...

Dec

2024

Hamlet BioPharma presenterar vid Financial Stockholm-evenemanget den 11 december 2024

Hamlet Biopharma

Press releases

Hamlet BioPharma AB, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar att företaget kommer att delta och...

Dec

2024

Hamlet BioPharmas styrelse har idag beslutat om en riktad nyemission av B-aktier om drygt 26 miljoner kronor

Hamlet Biopharma

Press releases

Hamlet BioPharma AB (”Hamlet BioPharma” eller ”Bolaget”), ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddel...

Nov

2024

Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024

Hamlet Biopharma

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s ...

Nov

2024

Kommuniké från årsstämma i Hamlet BioPharma AB

Hamlet Biopharma

Press releases

Vid årsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 21 november 2024 fattades de beslut som beskrivs ned...